Breath Molecular Diagnosis Market Trends and Forecast
The future of the global breath molecular diagnosis market looks promising with opportunities in the inflammatory breath test, helicobacter pylori breath test, and gastrointestinal flora metabolic disorder breath test markets. The global breath molecular diagnosis market is expected to grow with a CAGR of 8.4% from 2024 to 2030. The major drivers for this market are rising demand for non-invasive diagnostic methods, advancements in breath biomarker research, and growing prevalence of respiratory diseases.
• Lucintel forecasts that urea breath test is expected to witness higher growth over the forecast period.
• Within this market, inflammatory breath test is expected to witness the highest growth.
• APAC is expected to witness the highest growth over the forecast period.
Country Wise Outlook for the Breath Molecular Diagnosis Market
• United States: Companies like Owlstone Medical are expanding clinical trials for their breath biopsy platform, aiming to achieve FDA approval by 2025. Government initiatives support funding for research in non-invasive diagnostic technologies.
• Germany: BioMx has launched a new breath-based test for early cancer detection, targeting a 2023 market release. Government-backed grants encourage R&D in precision medicine and diagnostic innovations.
• China: Genetron Health is collaborating with local hospitals to integrate breath analysis into routine cancer screenings by 2024. Government policies incentivize adoption of advanced medical technologies to improve healthcare outcomes.
• Japan: Shimadzu Corporation is investing in breathomics research, aiming to commercialize a breath test for metabolic disorders by 2023. Government funding supports initiatives to develop innovative diagnostic tools for personalized healthcare.
A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.
Breath Molecular Diagnosis Market by Segment
The study includes a forecast for the global breath molecular diagnosis market by type, application, and region.
Breath Molecular Diagnosis Market by Type [Value from 2018 to 2030]:
• Urea Breath Test
• CO Breath Test
Breath Molecular Diagnosis Market by Application [Value from 2018 to 2030]:
• Inflammatory Breath Test
• Helicobacter Pylori Breath Test
• Gastrointestinal Flora Metabolic Disorder Breath Test
• Others
Breath Molecular Diagnosis Market by Region [Value from 2018 to 2030]:
• North America
• Europe
• Asia Pacific
• The Rest of the World
List of Breath Molecular Diagnosis Companies
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies breath molecular diagnosis companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the breath molecular diagnosis companies profiled in this report include-
• Quintron Instrument Company
• Circassia
• Bedfont Scientific
• Capnia
• Shenzhen Headway
• Beijing Wahenyida
• Wuxin Sunvon Medical Electronics
Recent Development in the Breath Molecular Diagnosis Market
• Owlstone Medical: Owlstone Medical has announced advancements in its Breath Biopsy® platform, enhancing its ability to detect early-stage cancers through volatile organic compounds (VOCs) analysis in exhaled breath. This development marks a significant step forward in non-invasive diagnostics.
• Aerocrine AB: Aerocrine AB has launched a new generation of FeNO (Fractional Exhaled Nitric Oxide) devices, designed to improve accuracy and usability in asthma management. The devices leverage breath analysis to provide real-time insights into airway inflammation, aiding in personalized treatment approaches.
• Actelion Pharmaceuticals: Actelion Pharmaceuticals is collaborating with research institutions to explore the potential of breath biomarkers in pulmonary hypertension. Their research aims to validate specific VOC profiles that could serve as diagnostic markers for this complex condition.
• Sensia: Sensia, a startup specializing in breath analysis technologies, has secured funding to further develop its portable breathalyzer for detecting early signs of infectious diseases. Their innovative approach targets rapid, point-of-care diagnostics using breath samples.
• Breathonix: Breathonix has received regulatory approval for its breath analysis technology in detecting COVID-19. Their device offers quick results with high accuracy, contributing to efforts in pandemic control and management.
Features of the Global Breath Molecular Diagnosis Market
Market Size Estimates: Breath molecular diagnosis market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
Segmentation Analysis: Breath molecular diagnosis market size by type, application, and region in terms of value ($B).
Regional Analysis: Breath molecular diagnosis market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different types, applications, and regions for the breath molecular diagnosis market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the breath molecular diagnosis market.
Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
FAQ
Q1. What is the growth forecast for breath molecular diagnosis market?
Answer: The global breath molecular diagnosis market is expected to grow with a CAGR of 8.4% from 2024 to 2030.
Q2. What are the major drivers influencing the growth of the breath molecular diagnosis market?
Answer: The major drivers for this market are rising demand for non-invasive diagnostic methods, advancements in breath biomarker research, and growing prevalence of respiratory diseases.
Q3. What are the major segments for breath molecular diagnosis market?
Answer: The future of the breath molecular diagnosis market looks promising with opportunities in the inflammatory breath test, helicobacter pylori breath test, and gastrointestinal flora metabolic disorder breath test markets.
Q4. Who are the key breath molecular diagnosis market companies?
Answer: Some of the key breath molecular diagnosis companies are as follows:
• Quintron Instrument Company
• Circassia
• Bedfont Scientific
• Capnia
• Shenzhen Headway
• Beijing Wahenyida
• Wuxin Sunvon Medical Electronics
Q5. Which breath molecular diagnosis market segment will be the largest in future?
Answer: Lucintel forecasts that urea breath test is expected to witness higher growth over the forecast period.
Q6. In breath molecular diagnosis market, which region is expected to be the largest in next 5 years?
Answer: APAC is expected to witness the highest growth over the forecast period.
Q7. Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% customization without any additional cost.
This report answers following 11 key questions:
Q.1. What are some of the most promising, high-growth opportunities for the breath molecular diagnosis market by type (urea breath test and co breath test), application (inflammatory breath test, helicobacter pylori breath test, gastrointestinal flora metabolic disorder breath test, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?
For any questions related to Breath Molecular Diagnosis Market Market, Breath Molecular Diagnosis Market Market Size, Breath Molecular Diagnosis Market Market Growth, Breath Molecular Diagnosis Market Market Analysis, Breath Molecular Diagnosis Market Market Report, Breath Molecular Diagnosis Market Market Share, Breath Molecular Diagnosis Market Market Trends, Breath Molecular Diagnosis Market Market Forecast, Breath Molecular Diagnosis Market Companies, write Lucintel analyst at email: helpdesk@lucintel.com. We will be glad to get back to you soon.